Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b76c30c1bbba1b914128ccb35683e0b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-244 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 |
filingDate |
2019-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de08c2d7c710854f3cd21bb48bcc361f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5a93bead49bfefde98cf034f62a5179 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e674786b089a6806e0d4bdf8704e4ea |
publicationDate |
2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2019249628-A1 |
titleOfInvention |
Bladder cancer photodynamic therapeutic agents with off-on magnetic resonance imaging enhancement |
abstract |
Provided herein are are porphyrinato-lanthanide complexes useful as theranostic agents and methods of preparation and use thereof. The porphyrinato-lanthanide complexes are useful in the treatment and imaging of cancer. |
priorityDate |
2018-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |